[ORGANIZATION]
Infarmed
Featured in 2 tracked stories · first seen
Situations
Diabetes medication access and costs in Portugal
2 clusters · 9 sources · last updated
Latest: Diabetic patients in Portugal lose access to subsidized medication
In Portugal, the medicines regulator Infarmed authorized the commercialization of generic dapagliflozin, which is 50% cheaper than the brand-name drug Forxiga. This measure aims to treat type 2 diabetes, chronic kidney d
Also covered in
-
Infarmed reports 12,349 suspected adverse drug reactions in 2025
[HEALTH] · 2 sources ·